Lancashire and South Cumbria
Formulary
 
back
1 Gastro-intestinal system
01-05-02 Corticosteroids



Prednisolone (oral)
Formulary

Tablets 1mg, 5mg
e/c tablets 2.5mg

First line oral corticosteroid treatment.

25mg tablets are classified as Do Not Prescribe.

There is no evidence that e/c prednisolone reduces the risk of gastrointestinal side effects. Uncoated 5mg tablets should be prescribed first line together with a PPI if necessary.

Link  MHRA: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration

Green View adult BNF  View SPC online  View childrens BNF
Prednisolone (rectal)
Formulary

Foam 20mg/metered application,
Retention enema 20mg/100mL,
Suppositories 5mg

Prednisolone rectal preparations are reserved for patients who do not respond to budesonide rectal.


Amber 0 View adult BNF  View SPC online  View childrens BNF
Budesonide Budenofalk®
Formulary

e/c capsules 3mg
e/c granules 9mg/sachet
Foam enema

First line rectal treatment (foam enema)


Amber 0 View adult BNF  View SPC online  View childrens BNF
Budesonide Entocort®
Formulary

Capsules 3mg, Enema


Amber 0 View adult BNF  View SPC online  View childrens BNF
Budesonide Kinpeygo®
Formulary

Modified release capsules 4mg (targeted release)

For treating primary IgA nephropathy in accordance with NICE TA937

Link  NICE TA937: Targeted-release budesonide for treating primary IgA nephropathy

Red View adult BNF  View SPC online  View childrens BNF
Budesonide  Cortiment MMX®
Formulary

Tablets, M/R 9 mg

Link  LSCMMG: Budesonide multimatrix (MMX)

Amber 0 View adult BNF  View SPC online  View childrens BNF